ACM Research, Inc. logo ACMR - ACM Research, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $113.20 DETAILS
HIGH: $136.00
LOW: $75.00
MEDIAN: $125.00
CONSENSUS: $113.20
UPSIDE: 43.09%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 326.2% above fair value
Current Price $79.11
Bear Case $13.92 82.4% downside ($13.92 - $79.11) / $79.11 = -82.4% $1.16 × 12x
Fair Value $18.56 76.5% downside ($18.56 - $79.11) / $79.11 = -76.5% $1.16 × 16x
Bull Case $23.20 70.7% downside ($23.20 - $79.11) / $79.11 = -70.7% $1.16 × 20x

Adjust Assumptions

16.0x
1.16$

Key Value Driver

Through-cycle normalized EPS ($1.16)

Implied Market Multiple 68.2x

Plain-Language Summary

Using 7-year normalized EPS of $1.16 at a 16x cycle multiple, the base-case value is $18.56 per share. P/TBV cross-check: 3.5x.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (10 analysts) $113.20
Analyst Range $75.00 – $136.00
Divergence from AlphaVal 84%

Warnings

Price-to-book value of 3.5x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $113.20 (from 10 analysts). Our estimate is 84% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing